Craig M. Kessler

18.2k total citations · 5 hit papers
294 papers, 11.6k citations indexed

About

Craig M. Kessler is a scholar working on Hematology, Genetics and Internal Medicine. According to data from OpenAlex, Craig M. Kessler has authored 294 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 215 papers in Hematology, 68 papers in Genetics and 48 papers in Internal Medicine. Recurrent topics in Craig M. Kessler's work include Hemophilia Treatment and Research (149 papers), Platelet Disorders and Treatments (92 papers) and Blood Coagulation and Thrombosis Mechanisms (59 papers). Craig M. Kessler is often cited by papers focused on Hemophilia Treatment and Research (149 papers), Platelet Disorders and Treatments (92 papers) and Blood Coagulation and Thrombosis Mechanisms (59 papers). Craig M. Kessler collaborates with scholars based in United States, United Kingdom and Italy. Craig M. Kessler's co-authors include Midori Shima, Mary Cushman, Rebecca Kruse‐Jarres, Peter W. Collins, Steven R. Deitcher, Alice J. Cohen, U. Martinowitz, Samuel Z. Goldhaber, Helena M. Jacobs and F. Baudo and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Craig M. Kessler

285 papers receiving 11.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emicizumab Prophylaxis in Hemophilia A with Inhibitors

2017 759 citations Rebecca Kruse‐Jarres, Craig M. Kessler et al. profile →
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism

2003 551 citations Samuel Z. Goldhaber, Steven R. Deitcher et al. profile →
Effect of Postmenopausal Hormones on Inflammation-Sensitive Proteins

1999 537 citations Craig M. Kessler et al. profile →
Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination

2021 270 citations Eun‐Ju Lee, Douglas B. Cines et al. American Journal of Hematology profile →
International recommendations on the diagnosis and treatment of acquired hemophilia A

2020 183 citations Andreas Tiede, Jerome Teitel et al. profile →

Peers

Countries citing papers authored by Craig M. Kessler

Since Specialization

Citations

This map shows the geographic impact of Craig M. Kessler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig M. Kessler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig M. Kessler more than expected).

Fields of papers citing papers by Craig M. Kessler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig M. Kessler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig M. Kessler. The network helps show where Craig M. Kessler may publish in the future.

Co-authorship network of co-authors of Craig M. Kessler

This figure shows the co-authorship network connecting the top 25 collaborators of Craig M. Kessler. A scholar is included among the top collaborators of Craig M. Kessler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig M. Kessler. Craig M. Kessler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Operationalising a Haemophilia Gene Editing Lexicon for Practical Use 2025 ·Haemophilia ·(unknown), Cédric Hermans, Carmen Unzu, Mark A. Kay, Flora Peyvandi, Paul Smith, Wolfgang Miesbach, Glenn F. Pierce, Kate Khair, Leonard A. Valentino, Steven W. Pipe, (unknown), (unknown), (unknown), (unknown), David E. Gutstein, Craig M. Kessler	0
2	Risk of myeloproliferative neoplasms among U.S. Veterans from Korean, Vietnam, and Persian Gulf War eras 2024 ·American Journal of Hematology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Guoqing Diao, (unknown), Craig M. Kessler, Minish Jain	1
3	A novel gene editing lexicon strategy for the haemophilia community: Research plan for development and preliminary results 2024 ·Haemophilia ·Cédric Hermans, Leonard A. Valentino, Courtney D. Thornburg, Carmen Unzu, Mark A. Kay, Flora Peyvandi, Paul Smith, Wolfgang Miesbach, (unknown), Glenn F. Pierce, Kate Khair, Steven W. Pipe, (unknown), (unknown), (unknown), (unknown), (unknown), Craig M. Kessler	2
4	Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort 2024 ·Blood Advances ·(unknown), (unknown), Annette von Drygalski, (unknown), (unknown), Aric Parnes, Evan C. Chen, (unknown), Patrick Ellsworth, (unknown), Christopher A. Walsh, Miguel A. Escobar, James Fan Wu, Lynn Malec, Craig M. Kessler, (unknown), Rebecca Kruse‐Jarres	1
5	Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years 2024 ·Journal of Thrombosis and Haemostasis ·Neil A. Goldenberg, Sam Schulman, John M. Kittelson, Thomas C. Abshire, James F. Casella, Rita Dale, Jonathan L. Halperin, (unknown), Craig M. Kessler, Marilyn J. Manco‐Johnson, (unknown), Robert F. Sidonio, Alex C. Spyropoulos, Philippe Gabríel Steg, Marc P. Bonaca, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
6	SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP 2021 ·Blood ·Eun‐Ju Lee, Marina Beltrami Moreira, Hanny Al‐Samkari, Adam Cuker, (unknown), Terry Gernsheimer, (unknown), Craig M. Kessler, Caroline Kruse, Andrew D. Leavitt, Alfred Ian Lee, Howard A. Liebman, Adrian C. Newland, (unknown), Michael D. Tarantino, Jecko Thachil, David J. Kuter, Douglas B. Cines, James B. Bussel	47
7	Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: A global expert consensus statement 2019 ·Haemophilia ·Andreas Tiede, Paul Giangrande, Jerome Teitel, Kagehiro Amano, Gary Benson, László Nemes, Víctor Jiménez‐Yuste, Roseline d’Oiron, (unknown), Craig M. Kessler	27
8	Methodologies for data collection in congenital haemophilia with inhibitors (CHwI): critical assessment of the literature and lessons learned from recombinant factor VIIa 2018 ·Haemophilia ·Craig M. Kessler, (unknown), Andrew Worster	3
9	Self‐reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P‐FiQ) study 2017 ·Haemophilia ·Michelle Witkop, Anne T. Neff, Tyler W. Buckner, Michael Wang, Katharine Batt, Craig M. Kessler, Doris Quon, Lisa Boggio, Michael Recht, Kim Baumann, Robert Gut, David L. Cooper, Christine L. Kempton	99
10	The Coags Uncomplicated App: Fulfilling Educational Gaps Around Diagnosis and Laboratory Testing of Coagulation Disorders 2017 ·JMIR Medical Education ·Craig M. Kessler, Ellinor I.B. Peerschke, Meera Chitlur, Roshni Kulkarni, (unknown), (unknown)	2
11	Retrievable inferior vena cava filters in patients with cancer are safe but are they beneficial? 2015 ·Medical Oncology ·Sameh Mikhail, Lindsay M. Hannan, Michael J. Pishvaian, Craig M. Kessler	9
12	Dalteparin sodium for the long-term management of venous thromboembolism in cancer patients. The DALTECAN Study 2013 ·Journal of Thrombosis and Haemostasis ·A.K. Kakkar, Craig M. Kessler, Samuel Z. Goldhaber, M.J. Kovacs, Alex C. Spyropoulos, Thomas L. Ortel, Ingrid Pabinger, M.V. Huisman, David Bergqvist, M. Monreal, Alexander G.G. Turpie, C. W. Francis	8
13	Modern treatment options for von Willebrand disease and haemophilia B - What are the benefits for the patients? 2011 ·Thrombosis and Haemostasis ·Paul Giangrande, Mario von Depka, Craig M. Kessler, Christoph Kannicht, Rolf Ljung	0
14	Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period 2006 ·Clinical and Applied Thrombosis/Hemostasis ·Steven R. Deitcher, Craig M. Kessler, Geno J. Merli, James R. Rigas, Roger M. Lyons, Jawed Fareed	294
15	Antithrombin, heparin, and heparan sulfate 2002 ·Critical Care Medicine ·Steven M. Opal, Craig M. Kessler, Juergen Roemisch, Sigurd Knaub	111
16	Synoviorthesis in Haemophilia 2001 ·Christine A. Lee, Craig M. Kessler	1
17	The genetic basis of inhibitor development in haemophilia A 1998 ·Haemophilia ·(unknown), Craig M. Kessler, D. Varon, U. Martinowitz, M. Heim, Edward G. D. Tuddenham, John H. McVey	35
18	Towards achieving global haemophilia care — World Federation of Hemophilia programmes 1998 ·Haemophilia ·(unknown), Craig M. Kessler, D. Varon, U. Martinowitz, M. Heim, ChristineA. Lee	10
19	RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty 1994 ·Richard J. Friedman, Bruce L. Davidson, John A. Heit, Craig M. Kessler, C. Gregory Elliott, (unknown), (unknown), D Dall, DAVID R. CHANDLER, Denis B. Drennan, Mary R. Suchyta, (unknown), (unknown), Stephen R. Hoff, (unknown), (unknown), Thomas M. Hyers, (unknown), W M Johnson	89
20	Conclusion 1991 ·The American Journal of Medicine ·Craig M. Kessler	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact